Strides Pharma Science Ltd vs Syncom Formulations India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Strides Pharma Science Ltd is ₹ 1036 as of 30 Apr 15:30 . The P/E Ratio of Strides Pharma Science Ltd changed from 1.7 on March 2025 to 28.2 on March 2021 . This represents a CAGR of 307.29% over 2 yearsThe P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 years The Market Cap of Strides Pharma Science Ltd changed from ₹ 3111 crore on March 2022 to ₹ 7573 crore on March 2021 . This represents a CAGR of 19.47% over 5 yearsThe Market Cap of Syncom Formulations (India) Ltd changed from ₹ 916.79 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 years The revenue of Strides Pharma Science Ltd for the Dec '25 is ₹ 1301 crore as compare to the Sep '25 revenue of ₹ 1247 crore. This represent the growth of 4.29% The revenue of Syncom Formulations (India) Ltd for the Dec '25 is ₹ 120.64 crore as compare to the Sep '25 revenue of ₹ 126.97 crore. This represent the decline of -4.99% The ebitda of Strides Pharma Science Ltd for the Dec '25 is ₹ 339.48 crore as compare to the Sep '25 ebitda of ₹ 248.89 crore. This represent the growth of 36.4% The ebitda of Syncom Formulations (India) Ltd for the Dec '25 is ₹ 26.71 crore as compare to the Sep '25 ebitda of ₹ 23.65 crore. This represent the growth of 12.94% The net profit of Strides Pharma Science Ltd changed from ₹ 3349 crore to ₹ 208.12 crore over 7 quarters. This represents a CAGR of -79.56% The net profit of Syncom Formulations (India) Ltd changed from ₹ 7.63 crore to ₹ 18.91 crore over 7 quarters. This represents a CAGR of 67.97% The Dividend Payout of Strides Pharma Science Ltd changed from 28.66 % on March 2021 to 1.28 % on March 2025 . This represents a CAGR of -46.30% over 5 yearsThe Dividend Payout of Syncom Formulations (India) Ltd changed from 13.07 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years .

About Strides Pharma Science Ltd

Strides Pharma Science Limited was originally incorporated under the name 'Strides Arcolab Limited ' on June 28, 1990.
In FY 2016, Shasun Pharmaceuticals Limited merged with Strides Arcolab Limited forming a new identity 'Strides Shasun Limited', making it effective from 19 November, 2015 and name of the Company was changed to 'Strides Pharma Science Limited' from 'Strides Shasun Limited' effective on July 18, 2018. Strides Pharma Science is a global pharmaceutical company headquartered in Bengaluru, India.
The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.

About Syncom Formulations (India) Ltd

Incorporated as a private limited Company in 1988, Syncom Formulations (India) Limited was converted into a public limited Company in June, 1992.
The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

FAQs for the comparison of Strides Pharma Science Ltd and Syncom Formulations (India) Ltd

Which company has a larger market capitalization, Strides Pharma Science Ltd or Syncom Formulations (India) Ltd?

Market cap of Strides Pharma Science Ltd is 9,552 Cr while Market cap of Syncom Formulations (India) Ltd is 1,290 Cr

What are the key factors driving the stock performance of Strides Pharma Science Ltd and Syncom Formulations (India) Ltd?

The stock performance of Strides Pharma Science Ltd and Syncom Formulations (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Strides Pharma Science Ltd and Syncom Formulations (India) Ltd?

As of May 4, 2026, the Strides Pharma Science Ltd stock price is INR ₹1036.35. On the other hand, Syncom Formulations (India) Ltd stock price is INR ₹13.73.

How do dividend payouts of Strides Pharma Science Ltd and Syncom Formulations (India) Ltd compare?

To compare the dividend payouts of Strides Pharma Science Ltd and Syncom Formulations (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.